Abstract In this paper we analyze the economic effects of the European Court of Justice’s (CoJ’s) jurisdiction on national health care systems in Europe, especially in Germany. We focus on the CoJ’s decisions concerning European patients’ rights to choose freely among suppliers of...

Markets for pharmaceuticals belong to the most intensly regulated markets. Manufacturers of pharmaceutical products frequently argue that regulatory interventions impede innovative activities. In this paper we scrutinize two important changes of the regulatory framework of the market for...

Pharmacies are the main distributors for pharmaceutical products in Germany. Due to the legal framework there is little price competition in this segment. With the liberalisation of the market and the entry of Internet pharmacies we expect considerable price effects. But an accompanying...